Regenecyte is under clinical development by StemCyte and currently in Pre-Registration for Unspecified Hematological Disorders.

Regenecyte is under clinical development by StemCyte and currently in Pre-Registration for Unspecified Metabolic Disorders.

For 75 years, San Diego Blood Bank has grown alongside the city, evolving to meet the needs of a changing San Diego. It ...

January is one of the best times to save money, as you can take advantage of all the end-of-season sales. Ever since the clock struck ...

Celebrate advancements in bone marrow transplantation in India, offering hope and life-saving treatments for patients ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

Pandemic preparedness and cord blood bank woes were among the top health stories in 2024. Read more at straitstimes.com.

Both of them are entrepreneurs. Fisher in 1993 founded ViaCord, a cord blood stem-cell banking business that she helped take public and sold for $300M in 2007. More recently, she founded two advocacy ...

From the DBS leadership renewal to the Straits Times Index surging to a 17-year high, these are some events this year that ...

Spurs Sports & Entertainment (SS&E) is partnering with South Texas Blood & Tissue (STB&T) to collect lifesaving blood ...

Some see cord blood banking as a form of insurance against future illness. But many medical experts don’t support the practice of cord blood banking, saying the possible benefits are very slight. The ...

Brooke Enloe is a former banking editor at Forbes Advisor. She is an editor and writer, passionate about producing enlightening content for readers. Her articles are about recent banking news ...